Philip Morris International Inc (PM) Analyst Ratings & Price Targets

Philip Morris International Inc

PM · NYSE

Analyst Consensus

Buy

15 analysts

$186

Current

—

Low

$211

Average

—

High

Average target implies +13.44% versus the current price.

Analyst Ratings Synthesis

Consensus is Buy across 15 analysts, and the mean price target is $211. The supplied consensus does not report a low or high target, so target dispersion and the width of the range cannot be established. It also does not identify the most bullish or least bullish analyst, provide individual firms, or show any rating or target revisions during the week. Accordingly, the record supports a broad positive consensus but not a reliable map of where targets cluster beyond the stated mean. No substantive analyst disagreement behind the target spread is disclosed, and the supplied snippets do not fill those gaps.

Rating Actions

No individual rating actions have been captured for PMyet. Consensus figures above come from Nasdaq's aggregate feed.

Rating actions are extracted from published reporting. Each row links to its source.

Research Reports

See Which Recent 13F Filers Hold PMBNK Invest
Uncertain

Links to freely available third-party research. Outlook labels are our classification of each article's stance, not a rating of our own.

Covering Firms

B OF A GLBL RES

BARCLAYS CAPITA

CITIGROUP

CO FORECST

DEUTSCHE BK SEC

EDWARD JONES

GOLDMAN SACHS

JEFFERIES & CO.

JP MORGAN SECUR

MORGAN STANLEY

ROTHSCHILD REDB

STIFEL NICOLAUS

TD COWEN

UBS

ZACKS RESEARCH

Symbol: PM
Type: Stock
Sector: Health Care
Industry: Cigarettes
Exchange: NYSE

Philip Morris International is a leading international consumer goods company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company's current product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, nicotine pouch and e-vapor products. Our smoke-free products are available for sale in over 105 markets, and as of December 31, 2025, PMI estimates they were used by over 43 million legal-age consumers around the world, many of whom have moved away from cigarettes or significantly reduced their consumption. The smoke-free business accounted for 43% of PMI's first-quarter 2026 total net revenues. Since 2008, PMI has invested over $16 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes.

Key Issues

Bullish view

Philip Morris appeared in 27 of the 51 latest 13F filings reviewed for the June 30, 2026 reporting period, indicating that the stock remains widely held among recently reporting funds.

Bearish view

The 27-fund count does not show position sizes, purchases, sales, or conviction, and therefore cannot establish that institutions are becoming more bullish on PM.

Analyst Consensus

See all

Buy

15 analysts

$186

Current

—

Low

$211

Average

—

High

Average target implies +13.44% versus the current price.

Earnings History

BeatMissNo estimate

Philip Morris International Inc

Analyst Consensus

Analyst Ratings Synthesis

Rating Actions

Research Reports

Covering Firms

Peers